Topic
Metastatic Prostate Cancer
3 Podcasts • 1 Course on BackTable
Hear how experienced physicians manage Metastatic Prostate Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 71 • 07 Jul 2026
Exploring PARP Inhibitor Combinations in Prostate Cancer
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.
This podcast is supported by an educational grant from Pfizer.
More on Metastatic Prostate Cancer
Loading recent podcasts…
Tumor Board # 71
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 248
Jul 17, 2025
with Dr. Ricardo Sánchez-Ortiz, Dr. Jose Silva
Prostate biopsy is evolving rapidly, offering urologists more precision - but also more decisions. In this episode of...
2,700+ listens
Urology # 259
Sep 8, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
2,000+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.